Advances in pemphigus research, signaling, and acantholysis

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 5, 2010, Pages 675-687

  Bektas, M ^a   Runager, K ^a   Petersen, J S ^a,c   Rubenstein, D S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Blister; Pemphigus; Skin diseases

Indexed keywords

DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; HEAT SHOCK PROTEIN 27; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE P38; PEMPHIGUS ANTIBODY;

ACANTHOLYSIS; ANTIGEN BINDING; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL ADHESION; CELL FATE; CLINICAL FEATURE; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME INHIBITION; HISTOPATHOLOGY; HUMAN; INTRACELLULAR SIGNALING; KERATINOCYTE; MEDICAL RESEARCH; NONHUMAN; PEMPHIGUS;

EID: 78650744019     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (108)

1. Beutner EH, Jordan RE. Demonstration of skin antibodies in sera of pemphigus vulgaris patients by direct immunoflourescent staining. Proceedings of the Society of Experimental Biological Medicine 1964; 117: 505-10.
2. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982; 306: 1189-96.
3. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67: 869-77.
4. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999; 103: 461-8. (Pubitemid 29094045)
5. Wu H, Wang ZH, Yan A, Lyle S, Fakharzadeh S, Wahl JK et al. Protection against pemphigus foliaceus by desmoglein 3 in neonates.[comment]. N Engl J Med 2000; 343: 31-5. (Pubitemid 30447989)
6. Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-6.
7. Rosenbach M, Murrell DF, Bystryn JC, Dulay S, Dick S, Fakharzadeh S et al. Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol 2009; 129: 2404-10.
8. Pfütze M, Niedermeier A, Hertl M, Eming R. Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus. Eur J Dermatol 2007; 17: 4-11. (Pubitemid 46383213)
9. Diaz LA, Prisayanh PS, Dasher DA, Li N, Evangelista F, Aoki V et al. The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus. J Invest Dermatol 2008; 128: 667-75.
10. Qaqish BF, Prisayanh P, Qian Y, Andraca E, Li N, Aoki V et al. Development of an IgG4-based predictor of endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol 2009; 129: 110-8.
11. Qian Y, Clarke SH, Aoki V, Hans-Filhio G, Rivitti EA, Diaz LA. Antigen selection of anti-DSG1 autoantibodies during and before the onset of endemic pemphigus foliaceus. J Invest Dermatol 2009; 129: 2823-34.
12. Diaz LA, Arteaga LA, Hilario-Vargas J, Valenzuela JG, Li N, Warren S et al. Anti-desmoglein-1 antibodies in onchocerciasis, leishmaniasis and Chagas disease suggest a possible etiological link to Fogo selvagem. J Invest Dermatol 2004; 123: 1045-51.
13. Qian Y, Valenzuela JG, Flores G, Rivitti EA, Aoki V, Hans-Filhio G et al. IgG4 and IgE anti-Dsg1 auto-antibodies recognize Lutzomyia longipalpis salivary gland antigens. J Invest Dermatol 2010; 130: S20.
14. Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. Journal of Clinical Investigation 2000; 105: 625-31. (Pubitemid 30146509)
15. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. Journal of Investigative Dermatology 1990; 94: 327-31. (Pubitemid 20061641)
16. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirusexpressed recombinant desmogleins. Journal of Immunology 1997; 159: 2010-7. (Pubitemid 127484192)
17. Amagai M, Koch PJ, Nishikawa T, Stanley JR. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 1996; 106: 351-5. (Pubitemid 26094622)
18. Lenz P, Amagai M, Volc-Platzer B, Stingl G, Kirnbauer R. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool [see comments]. Arch Dermatol 1999; 135: 143-8. (Pubitemid 29098359)
19. Eyre RW, Stanley JR. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 1988; 81: 807-12.
20. Ding X, Aoki V, Mascaro JMJr, Lopez-Swiderski A, Diaz LA, Fairley JA. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. Journal of Investigative Dermatology 1997; 109: 592-6. (Pubitemid 27433607)
21. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinicai phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999; 40(2 Pt 1): 167-70. (Pubitemid 29072792)
22. Miyagawa S, Amagai M, Iida T, Yamamoto Y, Nishikawa T, Shirai T et al. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 1999; 141: 1084-7. (Pubitemid 30046199)
23. Amagai M, Hashimoto T, Shimizu N, Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994; 94: 59-67. (Pubitemid 24218077)
24. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003; 170: 2170-8.
25. Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005; 115: 888-99.
26. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. Journal of Cell Biology 1997; 137: 1091-102.
27. Hisamatsu Y, Amagai M, Garrod DR, Kanzaki T, Hashimoto T. The detection of IgG and IgA autoantibodies to desmocollins 1-3 by enzyme-linked immunosorbent assays using baculovirus-expressed proteins, in atypical pemphigus but not in typical pemphigus. Br J Dermatol 2004; 151: 73-83.
28. Nguyen VT, Ndoye A, Grando SA. Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 2000; 275: 29466-76.
29. Evangelista F, Dasher DA, Diaz LA, Prisayanh PS, Li N. E-cadherin is an additional immunological target for pemphigus autoantibodies. J Invest Dermatol 2008; 128: 1710-8.
30. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by pemphigus vulgaris autoimmunity. Am J Pathol 2000; 157: 1377-91.
31. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.[comment]. J Clin Invest 2000; 106: 1467-79.
32. Stanley JR, Ishii K, Siegel DL, Payne AS. Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy. Vet Dermatol 2009; 20: 327-30.
33. Mao X, Choi EJ, Payne AS. Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol 2009; 129: 908-18.
34. Anhalt GJ, Patel HP, Labib RS, Diaz LA, Proud D. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol 1986; 136: 113-7.
35. himoto K, Shafran KM, Webber PS, Lazarus GS, Singer KH. Anticell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J Exp Med 1983; 157: 259-72.
36. Woo TY, Hogan VA, Patel H, Anhalt GJ, Labib RS, Voorhees JJ et al. Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol 1983; 81(1 Suppl): 115s-21s.
37. Shimizu A, Ishiko A, Ota T, Tsunoda K, Amagai M, NishikawaT. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model. J Invest Dermatol 2004; 122: 1145-53. (Pubitemid 38651089)
38. Aoyama Y, Owada MK, Kitajima Y. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 1999; 29: 2233-40. (Pubitemid 29313098)
39. Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP et al. Desmosome signaling: inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorginization. J Biol Chem 2005; 280: 23778-84.
40. Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, Balmer V et al. A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol 2001; 153: 823-34.
41. Esaki C, Seishima M, YamadaT, Osada K, KitajimaY. Pharmacologic evidence for involvement of phospholipase C in pemphigus IgGinduced inositol 1, 4, 5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995; 105: 329-33.
42. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004; 279: 2135-46.
43. Osada K, Seishima M, Kitajima Y. Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol 1997; 108: 482-7. (Pubitemid 27148285)
44. Seishima M, Esaki C, Osada K, Mori S, Hashimoto T, Kitajima Y. Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1, 4, 5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol 1995; 104: 33-7.
45. Mascaró JM Jr, España A, Liu Z, Ding X, Swartz SJ, Fairley JA, Diaz LA. Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol 1997; 85: 90-6. (Pubitemid 27432007)
46. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF. Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 1986; 137: 2835-40.
47. Mahoney MG, Wang ZH, Stanley JR. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol 1999; 113: 22-5.
48. Rock B, Labib RS, Diaz LA. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest 1990; 85: 296-9. (Pubitemid 20030322)
49. Kitajima Y, Aoyama Y, Seishima M. Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell datachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. J Invest Dermatol 1999; 4: 137-44. (Pubitemid 29489037)
50. Berkowitz P, Chua M, Liu Z, Diaz LA, Rubenstein DS. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol 2008; 173: 1628-36.
51. Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS. p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A 2006; 103: 12855-60.
52. Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D. Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol 2006; 175: 721-7.
53. Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrinand dynamin-independent mechanism. J Biol Chem 2008; 283: 18303-13.
54. Jolly PS, Berkowitz P, Bektas M, Lee HE, Chua M, Diaz LA et al. p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem 2010; 285: 8936-41.
55. Heupel WM, Müller T, Efthymiadis A, Schmidt E, Drenckhahn D, Waschke J. Peptides targeting the desmoglein 3 adhesive interface prevent autoantibody-induced acantholysis in pemphigus. J Biol Chem 2009; 284: 8589-95.
56. Heupel WM, Zillikens D, Drenckhahn D, Waschke J. Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol 2008; 181: 1825-34.
57. Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D. Pemphigus foliaceus IgG causes dissociation of desmoglein 1 -containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest 2005; 115: 3157-65.
58. Hu P, Berkowitz P, O'Keefe EJ, Rubenstein DS. Keratinocyte adherens junctions initiate nuclear signaling by translocation of plakoglobin from the membrane to the nucleus. J Invest Dermatol 2003; 121: 242-51.
59. Hu P et al. Adherens junction-mediated signaling in human keratinocytes: support for the hypothesis. Journal of Investigative Dermatology 2001; 117: 481.
60. Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M et al. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem 2006; 281: 7623-34.
61. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H et al. Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. Embo J 2006; 25: 3298-309.
62. Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A et al. Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem 2008; 283: 8736-45.
63. van Riggelen J, Felsher DW. Myc and a Cdk2 senescence switch. Nat Cell Biol 2010; 12: 7-9.
64. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320-44.
65. Berkowitz P, Diaz LA, Hall RP, Rubenstein DS. Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol 2008; 128: 738-40.
66. Braga VM, Machesky LM, Hall A, Hotchin NA. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. Journal of Cell Biology 1997; 137: 1421-31.
67. Aoyama Y, Kitajima Y. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol 1999; 112: 67-71. (Pubitemid 29024708)
68. Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem 2007; 282: 17866-76. (Pubitemid 47100314)
69. Miron T, Vancompernolle K, Vandekerckhove J, Wilchek M, Geiger B. A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J Cell Biol 1991; 114: 255-61. (Pubitemid 21909795)
70. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J, Lutsch G. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem 1994; 269: 20780-4.
71. Geum D, Son GH, Kim K. Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. J Biol Chem 2002; 277: 19913-21.
72. Panasenko OO, Kim MV, Marston SB, Gusev NB. Interaction of me small heat shock protein with molecular mass 25 kDa (hsp25) with actin. Eur J Biochem 2003; 270: 892-901.
73. MO Perng, L Cairns, P Van den Ijssel, A Prescott, AM Hutcheson, RA Quinlan. Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J Cell Sci 1999; 112(Pt 13): 2099-112.
74. Duverger O, Paslaru L, Morange M. HSP25 is involved in two steps of the differentiation of PAM212 keratinocytes. J Biol Chem 2004; 279: 10252-60. (Pubitemid 38372631)
75. Lavoie JN, Hickey E, Weber LA, Landry J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J Biol Chem 1993; 268: 24210-4.
76. Lavoie JN, Lambert H, Hickey E, Weber LA, Landry J. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Molecular Cellular Biology 1995; 15: 505-16.
77. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 1997; 110(Pt 3): 357-68. (Pubitemid 27095655)
78. Papakonstanti EA, Stournaras C. Cell responses regulated by early reorganization of actin cytoskeleton. FEBS Lett 2008; 582: 2120-7.
79. Miron T, Wilchek M, Geiger B. Characterization of an inhibitor of actin polymerization in vinculin-rich fraction of turkey gizzard smooth muscle. Eur J Biochem 1988; 178: 543-53. (Pubitemid 19021857)
80. Azuma N, Akasaka N, Kito H, Ikeda M, Gahtan V, Sasajima T. Role of p38 MAP kinase in endothelial cell alignment induced by fluid shear stress. Am J Physiol Heart Circ Physiol 2001; 280: H189-97.
81. Du J, Zhang L, Yang Y, Li W, Chen L, Ge Y et al. ATP depletioninduced actin rearrangement reduces cell adhesion via p38 MAPKHSP27 signaling in renal proximal tubule cells. Cell Physiol Biochem 2010; 25(4-5): 501-10.
82. Okada T, Otani H, Wu Y, Kyoi S, Enoki C, Fujiwara H et al. Role of F-actin organization in p38 MAP kinase-mediated apoptosis and necrosis in neonatal rat cardiomyocytes subjected to simulated ischemia and reoxygenation. Am J Physiol Heart Circ Physiol 2005; 289: H2310-8.
83. Jia Y, Wu SL, Isenberg JS, Dai S, Sipes JM, Field L et al. Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the act in and intermediate filament cytoskeleton. Cell Stress Chaperones 2010; 15: 165-81.
84. Lee HE, Berkowitz P, Jolly PS, Diaz LA, Chua MP, Rubenstein DS. Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis. J Biol Chem 2009; 284: 12524-32.
85. Jonak C, Klosner G, Kokesch C, FOdinger D, HOnigsmann H, Trautinger F. Subcorneal colocalization of the small heat shock protein, hsp27, with keratins and proteins of the cornified cell envelope. Br J Dermatol 2002; 147: 13-9. (Pubitemid 34779432)
86. Evgrafov OV, Mersiyanova I, Irobi J, Van Den Bosch L, Dierick I, Leung CL et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004; 36: 602-6.
87. Robitaille H, Simard-Bisson C, Larouche D, Tanguay RM, Blouin R, Germain L. The small heat-shock protein Hsp27 undergoes ERKdependent phosphorylation and redistribution to the cytoskeleton in response to dual leucine zipper-bearing kinase expression. J invest Dermatol 2010; 130: 74-85.
88. O'Shaughnessy RF, Welti JC, Cooke JC, Avilion AA, Monks B, Birnbaum MJ et al. AKT-dependent HspB 1 (Hsp27) activity in epidermal differentiation. J Biol Chem 2007; 282: 17297-305.
89. McClaren M, Isseroff RR. Dynamic changes in intracellular localization and isoforms of the 27-kD stress protein in human keratinocytes. J Invest Dermatol 1994; 102: 375-81.
90. Wong JW, Shi B, Farboud B, McClaren M, Shibamoto T, Cross CE et al. Ultraviolet B-mediated phosphorylation of the small heat shock protein HSP27 in human keratinocytes. J Invest Dermatol 2000; 115: 427-34.
91. de Thonel A, Vandekerckhove J, Lanneau D, Selvakumar S, Courtois G, Hazoume A et al. HSP27 controls GATA-1 protein level during erythroid cell differentiation. Blood 2010 [Epub ahead of print].
92. Friedman MJ, Li S, Li XJ. Activation of gene transcription by heat shock protein 27 may contribute to its neuronal protection. J Biol Chem 2009; 284: 27944-51.
93. Chen Y, Currie RW. Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart. Inflamm Res 2005; 54: 338-43.
94. Miller H, Poon S, Hibbert B, Rayner K, Chen YX, O'Brien ER. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor beta: mechanistic insight into the vascular effects of estrogens. Arterioscler Thromb Vasc Biol 2005; 25:e10-4.
95. Sur R, Lyte PA, Southall MD. Hsp27 regulates pro-inflammatory mediator release in keratinocytes by modulating NF-kappaB signaling. J Invest Dermatol 2008; 128: 1116-22.
96. Gniadecki R, Jemec GB, Thomsen BM, Hansen M. Relationship between keratinocyte adhesion and death: anoikis in acantholytic diseases. Arch Dermatol Res 1998; 290: 528-32.
97. Pacheco-Tovar MG, Avalos-Diaz E, Vega-Memije E, Bollain-yGoytia JJ, López-Robles E, Hojyo-Tomoka MT et al. The final destiny of acantholytic cells in pemphigus is Fas mediated. J Eur Acad Dermatol Venereol 2009; 23: 697-701.
98. Wang X, Brégégère F, Frusiç-Zlotkin M, Feinmesser M, Michel B, Milner Y. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004; 9: 131-43.
99. Frusic-Zlotkin M, Pergamentz R, Michel B, David M, Mimouni D, Brégégère F et al. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients. Ann N Y Acad Sci 2005; 1050: 371-9.
100. Puviani M, Marconi A, Cozzani E, Pincelli C. Fas Iigand in pemphigus sera induces keratinocyte apoptosis through the activation of caspase-8. J Invest Dermatol 2003; 120: 164-7.
101. Cirillo N, Lanza M, De Rosa A, Cammarota M, La Gatta A, Gombos F et al. The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery. J Cell Biochem 2008; 103: 598-606.
102. Lanza A, Cirillo N. Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus. Br J Dermatol 2007; 156: 400-2.
103. Weiske J, Schöneberg T, Schröder W, Hatzfeld M, Tauber R, Huber O. The fate of desmosomal proteins in apoptotic cells. J Biol Chem 2001; 276: 41175-81.
104. Li N, Zhao M, Wang J, Liu Z, Diaz LA. Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin. J Immunol 2009; 182: 711-7.
105. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, DiazLatoud C et al. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000; 2: 645-52.
106. Wang X, Brégégère F, Soroka Y, Frusic-Zlotkin M, Milner Y. Replicative senescence enhances apoptosis induced by pemphigus autoimmune antibodies in human keratinocytes. FEBS Lett 2004; 567: 281-6.
107. Pelacho B, Natal C, España A, Sánchez-Carpintero I, Iraburu MJ, López-Zabalza MJ. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett 2004; 566: 6-10.
108. Schmidt E, Gutberlet J, Siegmund D, Berg D, Wajant H, Waschke J. Apoptosis is not required for acantholysis in pemphigus vulgaris. Am J Physiol Cell Physiol 2009; 296: C162-72.